Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery.

about

Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery.

Item

http://www.wikidata.org/entity/Q49927350

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Using in Vitro Evolution and W ...... r Antimalarial Drug Discovery.

@en

Using in Vitro Evolution and W ...... r Antimalarial Drug Discovery.

@nl

type

Item

label

Using in Vitro Evolution and W ...... r Antimalarial Drug Discovery.

@en

Using in Vitro Evolution and W ...... r Antimalarial Drug Discovery.

@nl

prefLabel

Using in Vitro Evolution and W ...... r Antimalarial Drug Discovery.

@en

Using in Vitro Evolution and W ...... r Antimalarial Drug Discovery.

@nl

P1476

Using in Vitro Evolution and W ...... or Antimalarial Drug Discovery

@en

P2093

Madeline R Luth

http://www.w3.org/2001/XMLSchema#string

Purva Gupta

http://www.w3.org/2001/XMLSchema#string

P2860

Spiroindolones, a potent compound class for the treatment of malaria

Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum

Molecular identification of a malaria merozoite surface sheddase

Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase

A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model

Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity

In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth

Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin

Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes

P304

301-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSINFECDIS.7B00276

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Winzeler

Sabine Ottilie

P577

2018-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29451780

http://www.w3.org/2001/XMLSchema#string

P921

Chin-hu̍t seng-bu̍t

antimalarial

biomedical investigative technique

P932

5848146

http://www.w3.org/2001/XMLSchema#string